Skip to content

Medical emergency? What to do

Genetic disease carries risk of sudden deafness

3-RXPublished July 4, 20071 min read

Key points

  • People diagnosed with a genetic disease called von Hippel-Lindau disease or VHL may suddenly experience hearing loss caused by a tumor, researchers advise in this week's Journal of the American Medical Association.
  • Tumors of the inner ear occur sporadically in the general population but may be particularly associated with VHL.
  • In 7 patients, the tumor had invaded the inner ear.
  • SOURCE: Journal of the American Medical Association, July 3, 2007.

People diagnosed with a genetic disease called von Hippel-Lindau disease or VHL may suddenly experience hearing loss caused by a tumor, researchers advise in this week's Journal of the American Medical Association.

VHL disease is characterized by the development of tumors in blood vessels in the retina of the eye and in the brain. Lesions and cysts can also develop in other parts of the body.

Tumors of the inner ear occur sporadically in the general population but may be particularly associated with VHL. These tumors are associated with significant impairment of hearing and balance, including sudden irreversible hearing loss, the new study confirms.

Dr. John A. Butman, of the National Institutes Health, Bethesda, Maryland, and colleagues studied 35 VHL patients with inner ear tumors, three of whom had tumors in both ears. The found that hearing loss was the most common symptom associated with inner ear tumors.

In 7 patients, the tumor had invaded the inner ear. In the other 31 ears, hearing loss developed gradually in 13 and suddenly in 14, while 4 had normal hearing.

Butman and colleagues say "early surgical intervention may be warranted" in people with inner ear tumors. Surgery for these tumors has been shown to safely and effectively alleviate symptoms while preserving hearing, they note.

SOURCE: Journal of the American Medical Association, July 3, 2007.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Cancer

Study finds gene links to common lymphoma cancer

Scientists have found three new gene variations linked to the development of Hodgkin lymphoma, one of the most common cancers in young adults, and say the findings should help in the development of better treatments.…

2 min read

Genetics

Researchers find 95 genes affecting cholesterol

A scan of the full human DNA sequence has turned up 95 genes that affect blood cholesterol, including a few affected by drugs on the market and others that might be the basis of new drugs, researchers said on…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.